$0.24
+0.02 (+8.84%)
Open$0.23
Previous Close$0.22
Day High$0.24
Day Low$0.22
52W High$5.99
52W Low$3.13
Volume—
Avg Volume491.1K
Market Cap17.66M
P/E Ratio33.35
EPS$0.13
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.95M | 2.89M | 2.41M |
| Net Income | -877,894 | -779,690 | -617,534 |
| Profit Margin | -29.8% | -27.0% | -25.7% |
| EBITDA | -957,867 | -819,475 | -798,278 |
| Free Cash Flow | -748,445 | -747,364 | -598,338 |
| Rev Growth | +6.0% | +2.0% | +0.0% |
| Debt/Equity | 0.66 | 0.66 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |